Neuro-Oncology News

Michael A. Caligiuri, MD, has been named president and physician-in-chief at City of Hope National Medical Center.

Michael A. Caligiuri, MD, has been named president and physician-in-chief at City of Hope National Medical Center.

Michael A. Caligiuri, MD, has been named president and physician-in-chief at City of Hope National Medical Center.

Michael A. Caligiuri, MD, has been named president and physician-in-chief at City of Hope National Medical Center.

One-fifth of patients with cancer experienced PTSD within several months of diagnosis, according to results of a prospective study published in Cancer.

Patients with newly diagnosed glioblastoma who used the Optune device more than 90% of the time had the greatest chance for survival, according to a company-issued press release.

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

The addition of lomustine to bevacizumab failed to confer a survival advantage for the treatment of progressive glioblastoma, according to results of a phase 3 EORTC clinical trial.

The FDA today authorized Integrated Mutation Profiling of Actionable Cancer Targets, or IMPACT, an in vitro diagnostic test that uses next-generation sequencing to rapidly identify the presence of mutations in 468 genes.

Alcohol use — whether light, moderate or heavy — increases cancer risk, and public health measures are needed to reduce high-risk alcohol consumption, according to an ASCO statement.